Nicotinell Fruit 2mg medicated chewing-gums

  • Name:

    Nicotinell Fruit 2mg medicated chewing-gums

  • Company:
    info
  • Active Ingredients:

    Nicotine-polacrilin

  • Legal Category:

    Supply through general sale

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 01/11/16

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 30/4/2018
print

Print ViewKeyword Search SmPC

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name Andrews Liver Salts Effervescent Powder Active Ingredients Citric Acid (Anhydrous), Magnesium sulfate (dihydrate), Sodium Hydrogen Carbonate
Medicine Name Corsodyl Aniseed 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl 1% w/w Dental Gel Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl Mint 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Day Nurse Capsules Active Ingredients Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride
Medicine Name Duofilm Cutaneous Solution Active Ingredients Lactic Acid, Salicylic Acid
Medicine Name Eurax 10% w/w Cream Active Ingredients Crotamiton
Medicine Name Excedrin 250 mg /250 mg /65 mg film-coated tablets Active Ingredients Aspirin, Caffeine, Paracetamol
Medicine Name Flixonase Allergy Relief Nasal Spray Active Ingredients Fluticasone Propionate
Medicine Name Lamisil 1% w/w Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil AT Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil Once 1% cutaneous solution Active Ingredients Terbinafine hydrochloride
Medicine Name Nicotinell Cool Mint 2mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Cool Mint 4mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 2mg medicated chewing-gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 4mg Medicated Chewing-Gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Mint 1mg Compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell Mint 2mg compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell TTS 10, 7 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Nicotinell TTS 20, 14 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Nicotinell TTS 30, 21 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Night Nurse Capsules Active Ingredients Dextromethorphan Hydrobromide, Paracetamol, Promethazine hydrochloride
Medicine Name Night Nurse Cold Remedy Active Ingredients Dextromethorphan Hydrobromide, Paracetamol, Promethazine hydrochloride
Medicine Name Oilatum Cream Active Ingredients Light Liquid Paraffin, White Soft Paraffin
Medicine Name Oilatum Emollient 63.4% w/w Bath Additive Active Ingredients Light Liquid Paraffin
1 - 0 of 52 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 30 April 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through general sale

Updated on 1 November 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 1 November 2016 PIL

Reasons for updating

  • Improved presentation of PIL

Updated on 27 October 2016 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number

Updated on 3 October 2016 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text
  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - MA number

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Sections 7, 8 & 10 updated following Change of Ownership approval

Updated on 3 October 2016 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through general sale

Updated on 3 May 2016 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 4 September 2015 SmPC

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.8 - Undesirable effects
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 2

“with known effect”

Section 4.2

Subheadings added and method of administration information put into separate subsection

Section 4.3

“listed in section 6.1” added

Section 4.8


Adverse events tabulated and adverse events reporting statement added


Section 10

From 18 August 2014 to 24 June 2015

Updated on 2 September 2014 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

SPC Update – Nicotinell Fruit 2mg medicated chewing-gum – 18 August 2014   

 

 

Section 7

 

Address changed to Camberley.

 

Section 10

 

Change of date from 20 January 2012 to 18 August 2014.

 

 

 

Updated on 22 March 2012 SmPC

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 9

Date of last renewal changed from 25 May 2005 to 20 January 2012-03-16

 

Section 10

Change of date from 28 January 2010 to 20 January 2012

Updated on 5 May 2010 SmPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 6.5

Addition of 120 pack size

 

Section 10

Date changed from May 2009 to 28 January 2010

Updated on 29 July 2009 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.3 - Preclinical safety data
  • Change to section 10 - Date of revision of the text
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of renewal of authorisation

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company



Section 2       

Addition of: Excipient(s): sorbital (0.2g), sodium (11.50mg) and butylhydroxytoluene (E321).

 

Section 4.1    

Words ‘Nicotinell treatment is indicated for the’ have been deleted

‘Patient counselling and support normally improve the success rate’ has replaced ‘Advice and support normally improve the success rate’.

 

Section 4.2    

Following paragraph :  If an adverse event occurs with the use of the high dose   form (4 mg medicated chewing-gum), use of the low dose form (2 mg medicated chewing-gum) should be considered.  Replaces: If an adverse event is noted when high dose forms are initiated, this should be replaced by the lower dosage form.

 

Deletion of paragraph:  Nicotinell gum is sugar free.

 

New paragraph:  The initial dosage should be individualised on the basis of the patients nicotine dependence.

 

Section 4.3    

Words ‘to nicotine’ added to hypersensitivity to any of the excipients.

 

Section 4.4    

‘People having problems with the joint of the jawbone and….’ added before ‘denture wearers experience …..’

Addition of: ‘Because Nicotinell Fruit medicated chewing-gums contain sorbital:’ before Patients with rare hereditary conditions…….

Paragraph beginning Nicotinell Fruit 2mg has addition of words ‘contains sweeteners, including Sorbitol’.

 

New paragraph: ‘The gum base contains butylhydroxytoluene (E321) which may cause local irritation to mucous membranes’.

 

Section 4.5    

Paragraph beginning ‘Smoking may lead to reduced….. words ‘reduction and’ have been deleted.

 

Section 4.6    

Title change from ‘Use during pregnancy and lactation’ to ‘Pregnancy and lactation’.

 

Section 4.8    

Addition of:  Non dose-dependent adverse reactions are as follows:  jaw muscle ache, erythema, urticaria, hypersensitivity, angioneurotic oedema and anaphylactic reactions.

 

New paragraph:  Excessive swallowing of nicotine which is released in the saliva may, at first, cause hiccups.  Those who are prone to indigestion may suffer initially from minor degrees of hyspepsia or heartburn:  slower chewing will usually overcome this problem.  Excessive consumption of nicotine gums by subjects who have not been in the habit of inhaling tobacco smoke, could possibly lead to nausea, faintness and headache.  Increased frequency of aphthous ulcer may occur after abstinence from smoking.

Gastrointestinal disorders.  New: flatulence, dyspepsia, salivary hypersecretion, stomatitis, oral pain, or pharyngolaryngeal pain.  Deleted from list: indigestion, heartburn, increased salivation, irritation or sore mouth or throat.

Cardiac disorders:  ‘Rare, atrial arrhythmia’ replaces ‘cardiac arrhythmias (eg atrial fibrillation)’.

 

New paragraph:  ‘Cold sores may develop in connection with smoking cessation, but any relation with the nicotine treatment is unclear’.

 

New paragraph: ‘The patient may still experience nicotine dependence after smoking cessation’.

 

Section 5.3    

New paragraph: ‘Nicotine was positive in some in vitro genotoxicity tests but there are also negative results with the same test systems’. Replaces: ‘No definite conclusion can be drawn on the genotoxic activity of nicotine in vitro’.

 

Section 6.5    

Addition of box containing 204 pieces of gum.

 

Section 6.6    

‘Used Nicotinell medicated chewing-gum should be disposed of with care’, replaces, ‘No special requirements’.

 

Section 9       

Date of last renewal changed from 25 May 2005 to 15 June 2005

 

Section 10     

Date of revision of the text changed from 25 May 2005 to May 2009

Updated on 15 July 2008 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through general sale